The Strange Allure of State 'Right-to-Try' Laws

174 JAMA Internal Medicine 1885 (2014)

Posted: 19 Aug 2015

See all articles by Patricia J. Zettler

Patricia J. Zettler

Ohio State University (OSU) - Michael E. Moritz College of Law

Henry T. Greely

Stanford Law School

Date Written: September 29, 2014

Abstract

State right-to-try laws revive a decades-long debate about balancing early access to unapproved medications for terminally ill patients with requirements for demonstrated safety and effectiveness. Although the legal approach is novel, there are many reasons to believe that the laws are likely to be futile. The laws also raise questions about the roles of the state and federal governments in overseeing drugs and medical devices.

Keywords: FDA, compassionate use, drugs, federalism, health law and policy

Suggested Citation

Zettler, Patricia J. and Greely, Henry (Hank) T., The Strange Allure of State 'Right-to-Try' Laws (September 29, 2014). 174 JAMA Internal Medicine 1885 (2014), Available at SSRN: https://ssrn.com/abstract=2646060

Patricia J. Zettler (Contact Author)

Ohio State University (OSU) - Michael E. Moritz College of Law ( email )

55 West 12th Avenue
Columbus, OH 43210
United States

Henry (Hank) T. Greely

Stanford Law School ( email )

559 Nathan Abbott Way
Stanford, CA 94305-8610
United States
650-723-2517 (Phone)
650-725-0253 (Fax)

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
396
PlumX Metrics